243 related articles for article (PubMed ID: 27544906)
21. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
[TBL] [Abstract][Full Text] [Related]
22. Repression of microRNA-130b by thyroid hormone enhances cell motility.
Lin YH; Wu MH; Liao CJ; Huang YH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Tsai MM; Chen CY; Lin TP; Yeh YH; Chen WJ; Lin KH
J Hepatol; 2015 Jun; 62(6):1328-40. PubMed ID: 25617495
[TBL] [Abstract][Full Text] [Related]
23. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.
Huang XH; Chen JS; Wang Q; Chen XL; Wen L; Chen LZ; Bi J; Zhang LJ; Su Q; Zeng WT
J Pathol; 2011 Nov; 225(3):463-72. PubMed ID: 21671467
[TBL] [Abstract][Full Text] [Related]
24. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
26. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.
Huang CY; Huang XP; Zhu JY; Chen ZG; Li XJ; Zhang XH; Huang S; He JB; Lian F; Zhao YN; Wu GB
Oncol Rep; 2015 Jun; 33(6):2889-98. PubMed ID: 25962360
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
28. miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker.
Yang J; Liu X; Yuan X; Wang Z
Oncol Rep; 2015 Sep; 34(3):1415-23. PubMed ID: 26134929
[TBL] [Abstract][Full Text] [Related]
29. miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3).
Zhang LY; Liu M; Li X; Tang H
J Biol Chem; 2013 Feb; 288(6):4035-47. PubMed ID: 23212913
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.
Kim HS; Lee KS; Bae HJ; Eun JW; Shen Q; Park SJ; Shin WC; Yang HD; Park M; Park WS; Kang YK; Nam SW
Oncotarget; 2015 Apr; 6(10):8089-102. PubMed ID: 25797269
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
Yunqiao L; Vanke H; Jun X; Tangmeng G
Hepatogastroenterology; 2014; 61(133):1302-7. PubMed ID: 25436301
[TBL] [Abstract][Full Text] [Related]
32. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
33. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
[TBL] [Abstract][Full Text] [Related]
34. Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.
Yau WL; Lam CS; Ng L; Chow AK; Chan ST; Chan JY; Wo JY; Ng KT; Man K; Poon RT; Pang RW
PLoS One; 2013; 8(3):e57882. PubMed ID: 23483935
[TBL] [Abstract][Full Text] [Related]
35. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.
Du C; Lv Z; Cao L; Ding C; Gyabaah OA; Xie H; Zhou L; Wu J; Zheng S
J Transl Med; 2014 Sep; 12():259. PubMed ID: 25240815
[TBL] [Abstract][Full Text] [Related]
36. miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.
Tao ZH; Wan JL; Zeng LY; Xie L; Sun HC; Qin LX; Wang L; Zhou J; Ren ZG; Li YX; Fan J; Wu WZ
J Exp Med; 2013 Apr; 210(4):789-803. PubMed ID: 23478189
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.
Tu K; Zheng X; Dou C; Li C; Yang W; Yao Y; Liu Q
Int J Mol Sci; 2014 Nov; 15(11):20486-99. PubMed ID: 25387077
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.
Kan H; Guo W; Huang Y; Liu D
FEBS Lett; 2015 Jan; 589(1):102-9. PubMed ID: 25436421
[TBL] [Abstract][Full Text] [Related]
39. MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression.
Zhang Y; Li T; Guo P; Kang J; Wei Q; Jia X; Zhao W; Huai W; Qiu Y; Sun L; Han L
Sci Rep; 2014 Sep; 4():6248. PubMed ID: 25175916
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells.
Wang J; Yang X; Ruan B; Dai B; Gao Y; Duan J; Qu S; Tao K; Dou K; Li H
Tumour Biol; 2015 Apr; 36(4):2447-56. PubMed ID: 25412960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]